DePuy ASR Hip Replacement Lawsuits: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey DePuy ASR Hip Recall Litigation
The Firm is actively filing DePuy ASR lawsuits on behalf of individuals who allegedly suffered serious complications, including metallosis and premature device failure, related to the 2010 DePuy ASR hip recall.
New York, New York (PRWEB) April 28, 2013
The next Case Management Conference in hundreds of DePuy ASR hip replacement lawsuits currently pending in New Jersey Superior Court has been scheduled for May 28th, Bernstein Liebhard LLP reports. Court documents indicate that some 637 claims stemming from the August 2010 DePuy ASR hip recall have been filed in the coordinated proceeding now underway in Bergen County Superior Court. (In Re DePuy ASR Hip Implants Litigation, BER-L-3971-11)
“We look forward to additional progress in this litigation, as well as the federal litigation underway in Ohio. Our Firm continues to receive inquiries from individuals who have allegedly suffered serious complications related to the DePuy ASR hip recall,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including hundreds of clients in DePuy ASR lawsuits. The Firm continues to offer free legal evaluations to anyone who suffered serious complications, allegedly due to this metal-on-meta hip implant device.
DePuy ASR Lawsuits
Court records indicate that there are more than 10,000 DePuy ASR hip lawsuits currently pending in courts throughout the U.S. The DePuy ASR hip recall was announced after the metal-on-metal hip implants were found to be failing in 12-13% of recipients within just five years of implantation. However, court documents recently unsealed in one DePuy ASR lawsuit included an internal analysis conducted by Johnson & Johnson in 2011 that indicated the recalled hip implants are likely to fail in nearly 40% of recipients within just 5 years of implantation.*
In the wake of the DePuy ASR hip recall, the U.S. Food & Drug Administration (FDA) launched a safety review of metal-on-metal hip implants. In January, the agency proposed a new rule that would make all-metal hips ineligible for the agency´s 510(k) clearance process, which allowed devices like the ASR to come to market without first undergoing human clinical trials. The FDA also advised doctors to consider metal ion testing in those experiencing symptoms of hip implant failure.***
The majority of DePuy ASR hip replacement lawsuits filed since the recall are pending in a multidistrict litigation underway in U.S. District Court, Northern District of Ohio, where Bernstein Liebhard LLP is actively filing claims. Court documents indicate that the first trial in that litigation will begin this June. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation — MDL 2197).
In addition, hundreds of claims have also been filed in state courts throughout the nation. Last month, a Los Angeles Superior Court jury awarded more than $8 million to a plaintiff in the nation´s first trial of a DePuy ASR lawsuit (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County). However, a jury in Chicago found for Johnson & Johnson in a second trial that was decided earlier this month. (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County). According to a report from The New York Times, documents disclosed in the course of both proceedings indicated that Johnson & Johnson and DePuy knew that the ASR was defective years before the recall was announced in 2010, but did not disclose this information to the public or the medical community.**
Individuals who suffered metallosis, premature device failure or other complications allegedly related to the DePuy ASR hip recall may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information regarding DePuy ASR hip replacement lawsuits is available on Bernstein Liebhard LLP´s website. For additional information, please contact one of our attorneys by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs´ Hot List,” recognizing the top plaintiffs´ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebdepuy-asr-hip-lawsuits/depuy-asr-hip-recall/prweb10677465.htm